These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3436743)

  • 1. Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
    Eisenhauer EA; Maroun JA; Fields AL; Walde PL
    Invest New Drugs; 1987 Dec; 5(4):375-8. PubMed ID: 3436743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
    Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
    Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
    Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
    Maroun JA; Maksymiuk A; Eisenhauer E; Stewart DJ; Young V; Pater J
    Cancer Treat Rep; 1986 Nov; 70(11):1327-8. PubMed ID: 3021326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE
    Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
    Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
    Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I-II trial of acivicin in adult acute leukemia.
    Powell BL; Craig JB; Capizzi RL; Richards F
    Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
    Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion.
    Earhart RH; Koeller JM; Davis TE; Borden EC; McGovren JP; Davis HL; Tormey DC
    Cancer Treat Rep; 1983; 67(7-8):683-92. PubMed ID: 6871883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
    Holdener EE; Hansen HH; Høst H; Bruntsch U; Cavalli F; Renard J; Pinedo HM; Rozencweig M
    Invest New Drugs; 1985; 3(1):63-6. PubMed ID: 3857219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of acivicin in patients with advanced cancer.
    Sridhar KS; Ohnuma T; Chahinian AP; Holland JF
    Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of acivicin in malignant mesothelioma.
    Falkson G; Vorobiof DA; Simson IW; Borden EC
    Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
    Falkson G; Cnaan A; Simson IW; Dayal Y; Falkson H; Smith TJ; Haller DG
    Am J Clin Oncol; 1990 Dec; 13(6):510-5. PubMed ID: 2173394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacological study of acivicin by 24-hour continuous infusion.
    Weiss GR; McGovren JP; Schade D; Kufe DW
    Cancer Res; 1982 Sep; 42(9):3892-5. PubMed ID: 7105049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of central nervous system toxicity of the antitumor antibiotic acivicin by concomitant infusion of an amino acid mixture.
    Williams MG; Earhart RH; Bailey H; McGovren JP
    Cancer Res; 1990 Sep; 50(17):5475-80. PubMed ID: 2386952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
    Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ferrazzi E; Pappagallo GL; Nicoletto O; Fornasiero A; Refatti F; Cartei G; Vinante O; Fiorentino MV
    Tumori; 1984 Jun; 70(3):297-300. PubMed ID: 6588671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.